SGX942: Clinical Trials

3 trials of SGX942, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow SGX942: new trials by email Literature Review of SGX942 trials Research Report on SGX942

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dusquetide for the Treatment of Behcet's Disease
Dusquetide - Behçet Disease
Phase 2CompletedSoligenix82024-11-182026-08-26
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
SGX942, Placebo - Squamous Cell Carcinoma of the Oral Cavity and Oropharynx, Oral Mucositis
Phase 3CompletedSoligenix2662017-12-042022-11-08
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
SGX942, Placebo - Oral Mucositis
Phase 2CompletedSoligenix1112013-12-012017-08-28

Conditions studied

Stomatitis (2)  ·  Behcet Syndrome (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Soligenix (3)

Countries

United States (2)  ·  Belgium (1)  ·  France (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Results publications

PMID 41400947